Browse > Article

Fermentation of Red Ginseng using CKDHC 0801 and CKDHC 0802  

Shin, Yong-Seo (Chong Kun Dang Healthcare Corp. Research Center)
Publication Information
Korean journal of food and cookery science / v.26, no.4, 2010 , pp. 469-474 More about this Journal
Abstract
In this study, we isolated two species of bacteria for the powerful biotrasnformation of ginsenosides from Kimchi and human feces. Using biochemical tests and 16s rRNA sequencing, the selected strains were identified as Latobacillusplantarum (CKDHC0801) and Lactobacillussakei (CKDHC0802). Changes in cell growth and pH were examined in red ginseng. CKDHC 0801 and CKDHC 0802 reached their maximum growth phase after 24 hr and 48 hr, respectively, whereas the combined culture of CKDHC 0801 and CKDHC 0802 showed higher cell growth than bacterial strain alone. During fermentation of CKDHC 0801 and the combined culture, the pH values decreased from 5.2 to 4.2 after 24 hr, but CKDHC 0802 reached pH of 4.2 after 3day. The identities of ginsenosides were biotransferred from high molecular (Rg1 and Rb2) to low molecular (Rg3, Rg5, Rk1, PPD) by fermentation of both bacteria. Therefore, the results of this study demonstrate that CKDHC 0801 and CKDHC 0802 could be used to enhance to effects of red ginseng.
Keywords
fermentation; red ginseng; biotransforming; Lac. plantarum; Lac. sakei;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Kim KR, Chung TY, Shin H, Son SH, Park KK, Choi JH, Chung WY. 2010. Red Ginseng Saponin Extract Attenuates Murine Collagen-Induced Arthritis by Reducing Pro-inflammatory Responses and Matrix Metalloproteinase-3 Expression. Biological & Pharmaceutical Bulletin 33(4):604-610   DOI   ScienceOn
2 Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, Kim DH. 2005. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28(4):652-656   DOI   ScienceOn
3 Xia ZY, Liu XY, Zhan LY, He YH, Luo T, Xia Z. 2005. Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease. J. Thorac. Cardiovasc. Surg. 130(2):258-264   DOI   ScienceOn
4 Akao T, Kanaoka M, Kobashi K. 1998. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administrationmeasurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21(3):245-249   DOI   ScienceOn
5 Odani T, Tanizawa H, Takino Y. 1983. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem. Pharm. Bull. 31(1):292-298   DOI   ScienceOn
6 Bae EA, Kim NY, Han MJ, Choo MK, Kim DH. 2003. Transformation of ginsenosides to compounds K (IH-901) by latic acid bacteria of human intestine. J. Microbiol. Biotechnol. 13:9-14   과학기술학회마을
7 Chi H, Kim DH, Ji GE. 2005. Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. Biol. Pharm. Bull. 28(11):2102-2105   DOI   ScienceOn
8 Lee HJ, Baek JH, Yang M, Han HU, Ko YD, Kim HJ. 1993. Characterizations of lactic acid bacterial community during kimchi fermentation by temperature downshift. Kor. J. Microbiol. 31:346-353
9 Lee SH, Jung BH, Kim SY, Lee EH, Chung BC. 2006. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol. Res. 54(1):46-49   DOI   ScienceOn
10 Leroy F, Luc DV. 2001. Growth of the bacterioncin-producing Lactobacillus sakei strain CTC 494 in MRS broth is strongly induced nutrient exhaustion: a nutrient depletion model for the growth of lactic acid bacteria. Applied and Environmental Microbiol. 67:4407-4413   DOI   ScienceOn
11 Kim HG, Kim KY, Cha CJ. 2007. Screening for ginsengfermenting microoragnisms capable of biotransforming ginsenosides. Kor. J. Microbiol. 43(2):142-146   과학기술학회마을
12 Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 550: 173-179   DOI   ScienceOn
13 Hasegawa H, Sung J-H, Matsumiya S, and Uchiyama M (1996) Main ginseng matabolites formed by intestinal bacteria. Planta. Med. 62:453-455   DOI   ScienceOn
14 Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M. 2008. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur. J. Neurol. 15(8):865-868   DOI   ScienceOn
15 Karikura M, Miyase T, Tanizawa H, Takino Y, Taniyama T, Hayashi T. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem. Pharm. Bull. 1990 38(10):2859-2861   DOI   ScienceOn
16 Kim DH, Yu KW, Bae EA, Park HJ, Choi JW. 1998. Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and antidiabetic activity of their metabolites. Biol. Pharm. Bull. 21(4):360-365   DOI   ScienceOn
17 Park S, Kim DH, Paek NS, Kim SS. 2006. Preparation and quality characteristics of the fermentation product of ginseng by lactic acid bacteria (FGL). J. Ginseng Res. 30:88-94   과학기술학회마을   DOI   ScienceOn
18 Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. 2008. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in wellcontrolled, type 2 diabetes: results of a randomized, doubleblind, placebo-controlled study of efficacy and safety. Nutr. Metab. Cardiovasc. Dis. 18(1):46-56   DOI   ScienceOn
19 Rowe GE, Margaritis A. 2004. Enzyme kinetic properties of α-1,4-glucosidase in Bacillus thuringiensis. Biochemical Engineering Journal. 17(2):121-128   DOI   ScienceOn
20 Strombom J, Sandberg F, Dencker L. 1985. Studies on absorption and distribution of ginsenoside Rg-1 by whole-body autoradiography and chromatography. Acta. Pharm. Suec. 22(3):113-22